NCT05871073View on ClinicalTrials.gov

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

February 4, 2023

Study Completion Date

March 5, 2023

Conditions
Lumbar Spinal StenosisLumbar Disc HerniationLumbar SpondylolisthesisLumbar Spine Instability
Interventions
DRUG

Ropivacaine 0.75% Injectable Solution

WOUND INFILTRATION AFTER SPINAL SURGERY

DRUG

dexamethasone 8mg

WOUND INFILTRATION AFTER SPINAL SURGERY

Trial Locations (1)

5000

Hopital Fattouma Burguiba Monastir, Monastir

All Listed Sponsors
lead

University Hospital Fattouma Bourguiba

OTHER